In Brief This Week: Fluidigm, Life Tech; Bio-Rad; Viracor-IBT Laboratories; PositiveID; ArrayIt; Peaccel, Polyclone; Cofactor Genomics | GenomeWeb

NEW YORK (GenomeWeb News) – Fluidigm said in its Form 10-Q last week that it will pay Life Technologies $1.0 million as part of a cross-license agreement reached between Fluidigm and Life Tech's Applied Biosystems business. Life Tech notified Fluidigm in mid-October that the payment is due and payable under the license agreement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.